跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Tolterodine L-Tartrate Sustained Release Capsules
Approved
化学药品
Tolterodine L-Tartrate Sustained Release Capsules
CATALENT PHARMA SOLUTIONS, LLC
🇨🇳 National Medical Products Administration
Approval Date
Feb 3, 2018
Approval ID
7MazXbKBzmN
Company
CATALENT PHARMA SOLUTIONS, LLC
Type
化学药品
Approval Details
Approval Id
7MazXbKBzmN
Approval Number
H20181074
Generic Name
酒石酸托特罗定缓释胶囊
Generic Name En
Tolterodine L-Tartrate Sustained Release Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
2mg
Reg Date
2018-02-03
Expired Date
2023-02-02
Company Name
CATALENT PHARMA SOLUTIONS, LLC
Company Address
Via Vittor Pisani 20, 20124 Milano, Italy
Production Company Name
CATALENT PHARMA SOLUTIONS, LLC
Production Company Address
1100 Enterprise Drive, Winchester, Kentucky, USA
Company Detail Path
/organization/catalent-pharma-solutions-llc-madison-wisconsin-united-states
Production Company Detail Path
/organization/catalent-pharma-solutions-llc-madison-wisconsin-united-states
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 3, 2018
Approval ID
7MazXbKBzmN
Type
化学药品
Back to NMPA Approvals
酒石酸托特罗定缓释胶囊 - NMPA Drug Approval Details